Anticancer

10-Deacetyl-7-xylosyl paclitaxel
Catalog No: CFN90837

10-Deacetyl-7-xylosyl paclitaxel has long been used in Chinese clinics to treat cancer, it may target mitochondrial permeability transition pore (mPTP).

Soyasaponin II
Catalog No: CFN93159

Soyasaponin II has antiviral effects, it can inhibit the replication of human cytomegalovirus, influenza virus, and human immunodeficiency virus type 1. Soyasaponin II has hepatoprotective actions towards immunologically induced liver injury on primary cultured rat hepatocytes. It can inhibit the conversion of fibrinogen to fibrin, it also can promote activation of the fibrinolytic system in a plasminogen-containing fibrin plate. Soyasaponins are a potential antitumor compound and the apoptosis induced by soyasaponins is a key antitumor mechanism.

Tamoxifen
Catalog No: CFN93321

Tamoxifen is currently the first-line therapy for treatment of hormone-dependent breast cancer, it acts as an estrogen agonist by preventing the skeletal alterations that result from ovarian hormone deficiency.

Cisplatin
Catalog No: CFN93261

Cisplatin is a antineoplastic chemotherapy drug which works by cross-linking with DNA and causing DNA damage in cancer cells, it can enhance the cell-killing effect of radiation, an effect whose intensity varies with the schedule of administration.

Lanatoside C
Catalog No: CFN96196

Lanatoside C, a cardiac glycoside, possesses the ability to inhibit the interchange of Na and K across cell membrane and is widely used to treat anti-arrhythmias and heart failure. Lanatoside C can effectively inhibit all four serotypes of dengue virus, flavivirus Kunjin, alphavirus Chikungunya and Sindbis virus as well as the human enterovirus 71, suggest that lanatoside C possesses broad spectrum antiviral activity against several groups of positive-sense RNA viruses.